Vitrolife AB (publ)
VTRLY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3,609,000 | $3,512,000 | $3,234,000 | $1,680,804 |
| % Growth | 2.8% | 8.6% | 92.4% | – |
| Cost of Goods Sold | $1,470,000 | $1,534,000 | $1,454,000 | $634,714 |
| Gross Profit | $2,139,000 | $1,978,000 | $1,780,000 | $1,046,090 |
| % Margin | 59.3% | 56.3% | 55% | 62.2% |
| R&D Expenses | $117,000 | $228,000 | $143,000 | $114,450 |
| G&A Expenses | $478,000 | $433,000 | $400,000 | $259,456 |
| SG&A Expenses | $1,232,000 | $1,117,000 | $1,002,000 | $503,741 |
| Sales & Mktg Exp. | $754,000 | $684,000 | $602,000 | $244,285 |
| Other Operating Expenses | $7,000 | $4,222,000 | $0 | $0 |
| Operating Expenses | $1,356,000 | $5,567,000 | $1,145,000 | $619,679 |
| Operating Income | $783,000 | -$3,589,000 | $654,000 | $435,379 |
| % Margin | 21.7% | -102.2% | 20.2% | 25.9% |
| Other Income/Exp. Net | -$109,000 | -$123,000 | -$117,000 | $24,969 |
| Pre-Tax Income | $674,000 | -$3,712,000 | $537,000 | $459,969 |
| Tax Expense | $160,000 | $139,000 | $143,000 | $116,405 |
| Net Income | $513,000 | -$3,851,000 | $394,000 | $341,000 |
| % Margin | 14.2% | -109.7% | 12.2% | 20.3% |
| EPS | 3.79 | -28.44 | 2.91 | 2.97 |
| % Growth | 113.3% | -1,077.3% | -2% | – |
| EPS Diluted | 3.78 | -28.44 | 2.91 | 2.97 |
| Weighted Avg Shares Out | 135,423 | 135,395 | 135,395 | 114,625 |
| Weighted Avg Shares Out Dil | 135,566 | 135,395 | 135,395 | 114,625 |
| Supplemental Information | – | – | – | – |
| Interest Income | $24,000 | $12,000 | $2,000 | $1,000 |
| Interest Expense | $98,000 | $94,000 | $44,000 | $10,000 |
| Depreciation & Amortization | $376,000 | $425,000 | $396,000 | $108,914 |
| EBITDA | $1,159,000 | -$3,193,000 | $977,000 | $579,000 |
| % Margin | 32.1% | -90.9% | 30.2% | 34.4% |